What are limiting factors on the way toward commercialization of AFC ECGs?
For several decades, AFC ECGs have been widely used on spacecrafts and submarines in the United States, Russia and Germany. At the same time their commercial potential for mass market was limited mainly by two factors: high cost of fuel cells and lack of practical and cost-effective system for removal of carbon dioxide (CO2) from incoming air, which otherwise forms insoluble sediments in alkaline electrolyte.
